Purpose: The study of cell-free DNA (cfDNA) enables sequential analysis of tumor cell-specific genetic alterations in patients with neuroblastoma.
Experimental Design: Eighteen patients with relapsing neuroblastoma having received lorlatinib, a third-generation ALK inhibitor, were identified (SACHA national registry and/or in the institution). cfDNA was analyzed at relapse for nine patients and sequentially for five patients (blood/bone marrow plasma) by performing whole-genome sequencing library construction followed by ALK-targeted ddPCR of the hotspot mutations [F1174L, R1275Q, and I1170N; variant allele fraction (VAF) detection limit 0.
The Bureau International des Poids et Mesures (BIPM) is developing a new transfer instrument to extend its centralized services for assessing the international equivalence of radioactive standards to new radionuclides. A liquid scintillation counter using the triple/double coincidence ratio method is being studied and tested in the CCRI(II)-P1.Co-60 pilot study.
View Article and Find Full Text PDFA bilateral comparison to determine the activity concentration of the same I solution was organized. As electron-capture radionuclide with a rather high atomic number, I must be regarded as difficult to measure. The situation is partly exacerbated by the fact that some established standardization methods, like photon-photon coincidence counting, can no longer be applied due to the unavailability of appropriate equipment and expertise.
View Article and Find Full Text PDF